$177 Million is the total value of Ghost Tree Capital, LLC's 51 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SERIES TRUSTput | $11,037,000 | – | 220,000 | +100.0% | 6.24% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $9,786,000 | – | 350,000 | +100.0% | 5.54% | – |
| CELG | New | CELGENE CORP | $9,028,000 | – | 90,202 | +100.0% | 5.11% | – |
| EW | New | EDWARDS LIFESCIENCES CORPcall | $8,821,000 | – | 100,000 | +100.0% | 4.99% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $8,465,000 | – | 450,000 | +100.0% | 4.79% | – |
| IWM | New | ISHARES TRput | $8,297,000 | – | 75,000 | +100.0% | 4.70% | – |
| HZNP | New | HORIZON PHARMA PLC | $7,042,000 | – | 425,000 | +100.0% | 3.98% | – |
| ABBV | New | ABBVIE INCcall | $5,712,000 | – | 100,000 | +100.0% | 3.23% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $5,684,000 | – | 140,000 | +100.0% | 3.22% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $5,569,000 | – | 40,000 | +100.0% | 3.15% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $5,351,000 | – | 100,000 | +100.0% | 3.03% | – |
| OPHT | New | OPHTHOTECH CORP | $5,072,000 | – | 120,000 | +100.0% | 2.87% | – |
| IHF | New | ISHARES TRus hlthcr pr etf | $4,818,000 | – | 39,500 | +100.0% | 2.73% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,299,000 | – | 40,000 | +100.0% | 1.87% | – |
| IHI | New | ISHARES TRu.s. med dvc etf | $3,062,000 | – | 25,000 | +100.0% | 1.73% | – |
| RMD | New | RESMED INC | $2,891,000 | – | 50,000 | +100.0% | 1.64% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTLcall | $2,630,000 | – | 100,000 | +100.0% | 1.49% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INCcall | $2,040,000 | – | 100,000 | +100.0% | 1.15% | – |
| STJ | New | ST JUDE MED INC | $2,008,000 | – | 36,500 | +100.0% | 1.14% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $2,007,000 | – | 25,253 | +100.0% | 1.14% | – |
| MDT | New | MEDTRONIC PLC | $1,993,000 | – | 26,578 | +100.0% | 1.13% | – |
| IHE | New | ISHARES TRu.s. pharma etf | $1,342,000 | – | 9,800 | +100.0% | 0.76% | – |
| LBIO | New | LION BIOTECHNOLOGIES INC | $1,270,000 | – | 250,000 | +100.0% | 0.72% | – |
| CHMA | New | CHIASMA INC | $687,000 | – | 75,000 | +100.0% | 0.39% | – |
| ENDP | New | ENDO INTL PLC | $678,000 | – | 24,100 | +100.0% | 0.38% | – |
| HRTX | New | HERON THERAPEUTICS INC | $475,000 | – | 25,000 | +100.0% | 0.27% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $355,000 | – | 18,500 | +100.0% | 0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.